[1]
Moore, A., Alonso-Llamazares, J. , Bhatia, N., Devani, A., Bukhalo, M., Draelos, Z., Gooderham, M., Kempers, S., Kircik, L. , Papp, K., Pariser, D., Sankeva, M., Sinclair, R. , Zirwas, M., Feng, A. , Burnett, P., Higham, R. and Berk, D. 2021. Once-Daily Roflumilast Foam 0.3% Improves Severity and Burden of Itch in Patients With Scalp and Body Psoriasis in a Randomized, Double-blind, Vehicle-Controlled Phase 2b Study. SKIN The Journal of Cutaneous Medicine. 5, 6 (Nov. 2021), s43. DOI:https://doi.org/10.25251/skin.5.supp.43.